Navigation Links
Cardia 7 Pleased to Announce its Cholesterol Reducing Purified Omega 7
Date:12/9/2013

CLEVELAND, Ohio, Dec. 9, 2013 /PRNewswire-iReach/ -- Cardia 7 today announces its purified Omega-7 product, Cardia 7, is now available. The new product, which contains the Omega 7 Fatty Acid (or Palmitoleic Acid), is proving to have excellent cardiovascular and other health benefits, even over Omega 3. Clinical studies suggest that purified Omega 7 lowers triglycerides, bad cholesterol (LDL), and C-Reactive Protein (CRP) while increasing good cholesterol (HDL) and lipid profiles. It also decreases insulin resistance, weight, chronic and acute inflammation, and hepatic fat accumulation, without side effects.

(Photo: http://photos.prnewswire.com/prnh/20131209/MN29957)

"We are seeing amazing benefits from this fatty acid. Research is proving that purified Omega-7 has even more substantial benefits over Omega 3. Just one softgel a day could reduce plaque in arteries, boost HDL, and improve insulin sensitivity and glucose metabolism," said Arnold Mausser, a representative from Cardia 7.

This essential fatty acid is found in plant and animal sources, especially in fish oil, and macadamia nuts. However, for positive benefits of Omega 7, palmitoleic acid (Omega 7) has to be purified from the saturated fatty acid, palmitic acid, which is always conjoined with palmitoleic acid (Omega 7) in its original source. Without a completely purified state, people could potentially experience negative health benefits from taking it. 

Cardia 7 is made with the most purified palmitoleic acid (Omega 7). It undergoes a 7-step purification process that expresses high levels of palmitoleic acid (C16:1n7) from fish oil while also removing the saturated fatty acid, palmitic acid (equivalent to trans-fat) to less than 1% which creates a (Palmitric Free) purified Omega-7.  Cardia 7 is the most pure source of Omega-7 fatty acids on the market.   When analyzing omega 7 products on the market, be sure to pay attention to the amount of palmitic acid in the product.  If it is over 1% it is not palmitic free, thus you will be consuming the equivalence of trans fat.

"This is good news. Cardia 7 can help in the fight against cardiovascular disease, such as those who have been diagnosed with cardiac risk factors, diabetes, and even weight management. No other natural product can say it has this much punch when it comes to fighting a variety of diseases," said Mausser.

Cardia 7 is only one of a select few who sell the purified form of Omega 7.  Since introducing Omega 7's extraordinary health benefits, many consumers are wanting to try this incredible fatty acid. It makes sense that clinics, holistic and wellness centers begin to carry the product as well," said Mausser.

About Cardia 7

Cardia 7 is a brand new product distributed online or at the Cleveland Clinic Wellness Center. It is one of the few products on the market that uses a patent-pending 7-step purification process to express high levels of the monosaturated fatty acid, palmitoleic acid (C16:1n7) or Omega 7, from fish oil while also removing the saturated fatty acid, palmitic acid reducing it to below 1% making it (Palmitic Free).

To order, go to Cardia 7's website at www.cardia7.com.

Media Contact: Jim Thrash, Cardia7, 440-550-4355, info@cardia7.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Cardia 7
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Case Report Published in the Journal Perfusion on 14-Year-Old Pediatric Patient Bridged to Transplant with SynCardia Total Artificial Heart
2. A Record 125 SynCardia Total Artificial Hearts Implanted by Surgeons Worldwide So Far in 2013
3. UK’s 1st SynCardia Total Artificial Heart Patient Bridged to Transplant at Papworth Hospital
4. Journal of Cardiothoracic Surgery Publishes 1st Case Report of Using Single-Site Cannulation ECMO to Treat SynCardia Total Artificial Heart Patient
5. French Man Surpasses Two Years of Support with SynCardia Total Artificial Heart
6. Over 50% of “Best Heart Hospitals” in U.S. News & World Report Are Certified to Implant the SynCardia Total Artificial Heart
7. 1st Pediatric SynCardia Total Artificial Heart Patient in Turkey Celebrates 18th Birthday
8. SynCardia Total Artificial Heart Surpasses 100th Implant of 2013
9. SynCardia Total Artificial Heart Bridges Mother of Four with Congenital Heart Defect & Biventricular Heart Failure to Transplant
10. Medical Design Excellence Awards Selects Companion 2 Hospital Driver for Powering SynCardia Total Artificial Heart as Silver Winner
11. 7 SynCardia Certified Centers Honored Among “Best Children’s Hospitals” for Cardiology and Heart Surgery by U.S. News & World Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2017)... ... ... ACEA Biosciences, a pioneer in cell analysis instrumentation and the development of ... as the new Vice President of Global Clinical Development. With more than 15 ... will now team with Dr. Li Xu, Chief Medical Officer, and Dr. Xiao Xu, ...
(Date:2/28/2017)... ... February 28, 2017 , ... ... science and biotechnology companies today announced it named Joan Siefert Rose as ... out of Durham, NC and will begin work immediately. , Rose most recently ...
(Date:2/28/2017)... , Feb. 28, 2017 Sangamo ... genome editing, today reported its fourth quarter and ... "Early this year we rebranded our ... clinical development of genomic therapies using our industry ... gene regulation and cell therapy," said Sandy ...
(Date:2/27/2017)... 2017 A Europe-wide survey of institutes conducted ... animals in their research treat them with due care. The survey ... analysis of the results indicates that there is a strong commitment ... into practice the principles of the 3Rs (Refine, Reduce, Replace)  ... What are the ...
Breaking Biology Technology:
(Date:2/3/2017)... A new independent identity strategy consultancy firm ... . Designed to fill a critical niche in technical ... partners Mark Crego and Janice Kephart ... identity expertise that span federal governments, the 9/11 Commission, ... combined expertise has a common theme born from a ...
(Date:1/31/2017)... , Jan. 31, 2017  Spero Therapeutics, ... therapies for the treatment of bacterial infections, today ... of antibacterial candidates from Pro Bono Bio Ltd ... prevalence of multi-drug resistant forms of Gram-negative bacteria.  ... Anti Infectives Ltd, a PBB group company. ...
(Date:1/24/2017)... Jan. 24, 2017 Biopharm Reports has ... laboratory use of nuclear magnetic resonance spectroscopy (NMR). ... and profiled current practices, developments, trends and end-user ... as growth and opportunities. These areas include growth ... instruments, needs and innovation requirements, hyphenated NMR techniques, ...
Breaking Biology News(10 mins):